通过孟德尔随机化分析在血和大脑中确定了喘潜在的药物标
Yuting Wang1, Jiaxi Wang1, Zhanfeng Yan2
1Department of Otorhinolaryngology, Dongfang Hospital Affiliated to Beijing University of Chinese Medicine, Beijing, China.
Frontiers in immunology
|October 9, 2023
概括
这项研究确定了三种蛋白IL1R1,ECM1和PDLIM4作为喘发展的潜在因果因素. 这些蛋白质可能是预防喘进展和改善患者治疗结果的新疗法标.
科学领域:
- 遗传学和基因组学 遗传学和基因组学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 喘是一种复杂的疾病,涉及神经性炎症,目前的治疗方法不足以控制复发和进展.
- 现有的喘药物主要集中在缓解症状上,强调需要新的药物点来阻止疾病的进展.
- 确定新的治疗点对于开发更有效的喘管理策略至关重要.
研究的目的:
- 通过使用孟德尔随机化来研究喘潜在的蛋白质药物标.
- 确定与喘风险因果相关的蛋白质,并探索它们的治疗潜力.
- 将已识别的蛋白质标与现有的喘药物的标进行比较.
主要方法:
- 来自英国生物银行总结统计数据的门德尔随机化分析,Demenais等. 在GWAS和FinnGen队列中.
- 利用血和大脑蛋白质的遗传仪器,采用反向因果关系分析和贝叶斯共定位.
- 进行了蛋白质-蛋白质相互作用分析,并将研究结果与现有的喘药物点进行了比较.
主要成果:
- 确定了五种重要的蛋白质 - 喘对,包括IL1R1和ECM1 (增加喘风险) 和ADAM19 (保护性) 在血中.
- 在大脑中,ECM1和PDLIM4与喘风险增加有关.
- 在复制队列中验证了IL1R1和PDLIM4,IL1R1与当前的喘药物标相互作用.
结论:
- 喘风险受到IL1R1,ECM1和PDLIM4.4的血和大脑水平的因果影响.
- 这三种蛋白质代表了对喘有前途的新药标.
- 需要进一步的临床试验来研究向IL1R1,ECM1和PDLIM4在喘中的治疗潜力.
相关概念视频
01:19Antiasthma Drugs: Leukotriene Modifiers
330
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
330
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
317
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
317
01:20Asthma: Pathogenesis and Management
425
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
425
01:26Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
01:29Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
282
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
282